Drug
Sertralin
Sertralin is a pharmaceutical drug with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
1(33%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_4
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution3 total trials
Phase 4Post-market surveillance
3(100.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(1)
Other(1)
Detailed Status
Completed1
unknown1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 43 (100.0%)
Trials by Status
completed133%
unknown133%
recruiting133%
Recent Activity
1 active trials
Showing 3 of 3
Clinical Trials (3)
Showing 3 of 3 trials
NCT07478796Phase 4
TDM-Guided Treatment With SSRIs in Hospitalized Adults and Children
NCT00433121Phase 4
Discontinuation of Antipsychotics and Antidepressants Among Patients With BPSD
NCT00226642Phase 4
Treatment of Mild and Subthreshold Depressive Disorders
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3